Terms: = Bone cancer AND CASC5, AF15Q14, 57082, ENSG00000137812, D40, Q8NG31
4 results:
1. [casc5 Gene Expression Changes Correlate with Targeted Mutations in Leukemia].
Bogdanov KV; Merzlikina OV; Mirolyubova YV; Girshova LL; Lomaia EG; Zaritskey AY
Mol Biol (Mosk); 2021; 55(1):139-151. PubMed ID: 33566033
[TBL] [Abstract] [Full Text] [Related]
2. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy.
Florijn MA; Sharfo AWM; Wiggenraad RGJ; van Santvoort JPC; Petoukhova AL; Hoogeman MS; Mast ME; Dirkx MLP
Radiother Oncol; 2020 Jan; 142():147-153. PubMed ID: 31522879
[TBL] [Abstract] [Full Text] [Related]
3. Fractionated stereotactic radiotherapy of benign skull-base tumors: a dosimetric comparison of volumetric modulated arc therapy with Rapidarc® versus non-coplanar dynamic arcs.
Martin F; Magnier F; Berger L; Miroir J; Chautard E; Verrelle P; Lapeyre M; Biau J
Radiat Oncol; 2016 Apr; 11():58. PubMed ID: 27090091
[TBL] [Abstract] [Full Text] [Related]
4. Correlation between intensity modulated radiotherapy and bone marrow suppression in breast cancer.
Wang Q; Ye T; Chen HL; Zhang XG; Zhang LZ
Eur Rev Med Pharmacol Sci; 2016; 20(1):75-81. PubMed ID: 26813456
[TBL] [Abstract] [Full Text] [Related]
